E-LIB Suche - Ergebnisse für: DiNardo, C. D.

1

BCL2 FAMILY INHIBITORS:

Dinardo, C.
Leukemia Research. 128 (2023) - p. 107101 , 2023

Link: https://doi.org/10.1016/..

2

POLIMORFISMOS GENÉTICOS E NÍVEIS DE FERRITINA EM PACIENTES ..:

Almeida, ACV ; Dinardo, C ; Ozahata, MC...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S10-S11 , 2023

Link: https://doi.org/10.1016/..

3

Dorsal Column Myelopathy Following Intrathecal Chemotherapy..:

Schrank, B.R. ; Manzar, G.S. ; Wu, S.Y....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e486-e487 , 2023

Link: https://doi.org/10.1016/..

4

FARMACOGENÔMICA DA ANEMIA FALCIFORME: AVALIAÇÃO DE POLIMORF..:

Almeida, ACV ; Dinardo, C ; Sabino, EC...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S989-S990 , 2023

Link: https://doi.org/10.1016/..

5

S127: QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) ..:

Yilmaz, M. ; Muftuoglu, M. ; Kantarjian, H....
HemaSphere. 6 (2022) - p. 28-29 , 2022

Link: https://doi.org/10.1097/..

6

P541: OUTCOMES AND MANAGEMENT OF PATIENTS WITH NEWLY DIAGNO..:

Haddad, F. ; Sasaki, K. ; Abuasab, T....
HemaSphere. 6 (2022) - p. 440-441 , 2022

Link: https://doi.org/10.1097/..

7

P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITH..:

Short, N. ; Kantarjian, H. ; Ravandi, F....
HemaSphere. 6 (2022) - p. 271-272 , 2022

Link: https://doi.org/10.1097/..

8

P510: THE IMPACT OF POST-REMISSION GRANULOCYTE COLONY-STIMU..:

DiNardo, C. ; Pratz, K. ; Panayiotidis, P....
HemaSphere. 6 (2022) - p. 409-410 , 2022

Link: https://doi.org/10.1097/..

9

P575: IMPACT OF MOLECULAR RESPONSE AND CHEMOTHERAPY REGIMEN..:

Senapati, J. ; Haddad, F. ; Ravandi, F....
HemaSphere. 6 (2022) - p. 474-475 , 2022

Link: https://doi.org/10.1097/..

10

P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WI..:

Haddad, F. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 255-256 , 2022

Link: https://doi.org/10.1097/..

11

P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TRE..:

Senapati, J. ; Kantarjian, H. ; Short, N....
HemaSphere. 6 (2022) - p. 268-269 , 2022

Link: https://doi.org/10.1097/..

12

P497: PROGNOSTIC IMPACT OF RAS AND C-KIT MUTATIONS (SINGLE ..:

Abuasab, T. ; Senapati, J. ; Kadia, T....
HemaSphere. 6 (2022) - p. 396-397 , 2022

Link: https://doi.org/10.1097/..

13

P496: CLINICAL CHARACTERISTICS OF SECONDARY MYELOID NEOPLAS..:

Abuasab, T. ; Mohadam, S. F. ; Hwang, H....
HemaSphere. 6 (2022) - p. 395-396 , 2022

Link: https://doi.org/10.1097/..

14

P590: PRELIMINARY SAFETY AND EFFICACY OF BGB-11417, A POTEN..:

Shortt, J. ; Tan, S. Y. ; Cannell, P....
HemaSphere. 6 (2022) - p. 489-490 , 2022

Link: https://doi.org/10.1097/..

15

P576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBIN..:

Senapati, J. ; Ishizawa, J. ; Abbas, H. A....
HemaSphere. 6 (2022) - p. 475-476 , 2022

Link: https://doi.org/10.1097/..